
Integer Holdings (ITGR) Stock Forecast & Price Target
Integer Holdings (ITGR) Analyst Ratings
Bulls say
Integer Holdings Corp reported a notable 15% revenue increase in its Cardio & Vascular segment for 3Q25, contributing to an optimistic growth forecast with anticipated revenues of $1.87 billion in 2026E, reflecting a 1.5% rise from the previous year. Gross margins are projected to remain steady, ranging from 27.0% to 27.3% through 2026, while operating cash flow is expected to improve significantly, reaching between $230-$240 million in 2025. Additionally, the robust cardiovascular device market, bolstered by new product innovation and favorable demographics, positions Integer favorably for sustained growth moving forward.
Bears say
Integer Holdings Corp is facing significant challenges reflected in revised revenue estimates for 4Q25E, now projected at $460.0 million, which marks a decrease from previous estimates and a modest increase from the prior year. The company's management has adjusted their full year 2025 guidance downward by $16 million and initiated a flat-to-lower growth outlook for 2026, citing reduced demand for key products that significantly impacts sales expectations. Additionally, a slowdown in market adoption for crucial programs and the potential for lower contributions from mergers and acquisitions raise concerns about the company's ability to meet growth targets, leading to expectations of a decline in adjusted operating income.
This aggregate rating is based on analysts' research of Integer Holdings and is not a guaranteed prediction by Public.com or investment advice.
Integer Holdings (ITGR) Analyst Forecast & Price Prediction
Start investing in Integer Holdings (ITGR)
Order type
Buy in
Order amount
Est. shares
0 shares